MedPath

Neomycin and Polymyxin B Sulfates and Bacitracin Zinc with Hydrocortisone Acetate

Approved
Approval ID

e76c3a5a-d417-473b-ab9a-165d9d9963c6

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 11, 2010

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Neomycin and Polymyxin B Sulfates and Bacitracin Zinc with Hydrocortisone Acetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-6122
Application NumberANDA062166
Product Classification
M
Marketing Category
C73584
G
Generic Name
Neomycin and Polymyxin B Sulfates and Bacitracin Zinc with Hydrocortisone Acetate
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateMay 17, 2010
FDA Product Classification

INGREDIENTS (7)

ZINC CHLORIDEInactive
Code: 86Q357L16B
Classification: IACT
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT
NEOMYCIN SULFATEActive
Quantity: 3.5 mg in 1 g
Code: 057Y626693
Classification: ACTIB
POLYMYXIN B SULFATEActive
Quantity: 10000 [USP'U] in 1 g
Code: 19371312D4
Classification: ACTIB
BACITRACIN ZINCActive
Quantity: 400 [USP'U] in 1 g
Code: 89Y4M234ES
Classification: ACTIB
HYDROCORTISONE ACETATEActive
Quantity: 10 mg in 1 g
Code: 3X7931PO74
Classification: ACTIB
MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Neomycin and Polymyxin B Sulfates and Bacitracin Zinc with Hydrocortisone Acetate - FDA Drug Approval Details